18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

Arnoldo Piccardo, Egesta Lopci, Luca Foppiani, Giovanni Morana, Massimo Conte

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Functional imaging plays a crucial role in the assessment of neuroblastoma. The evaluation of response to induction chemotherapy is a cornerstone in scheduling proper treatment management in patients affected by high-risk neuroblastoma. 123I-metaiodobenzylguanidine has been recognized as the radiopharmaceutical of choice in neuroblastoma assessment. To date, the clinical role of PET/CT in pediatric malignancy is not well established. 18F-DOPA-PET/CT has been recently used in neuroblastoma, and compared with 123I-MIBG-scan. Scant new data are available about the role of this tool in the evaluation of treatment response after induction chemotherapy. We investigate the role of 18F-DOPA-PET/CT in characterizing the response to induction chemotherapy in a child affected by high-risk- neuroblastoma, in whom the rare association of 123I-MIBG-negative primary tumor and MIBG-positive bone marrow metastases was observed.

Original languageEnglish
Pages (from-to)355-361
Number of pages7
JournalPediatric Radiology
Volume44
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Induction Chemotherapy
Neuroblastoma
3-Iodobenzylguanidine
Radiopharmaceuticals
Neoplasms
Bone Marrow
Pediatrics
Neoplasm Metastasis
Therapeutics

Keywords

  • Child
  • Neuroblastoma
  • Positron emission tomography/computed tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pediatrics, Perinatology, and Child Health

Cite this

18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma. / Piccardo, Arnoldo; Lopci, Egesta; Foppiani, Luca; Morana, Giovanni; Conte, Massimo.

In: Pediatric Radiology, Vol. 44, No. 3, 2014, p. 355-361.

Research output: Contribution to journalArticle

@article{42d2ec1179344b42a73116b40d8b9310,
title = "18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma",
abstract = "Functional imaging plays a crucial role in the assessment of neuroblastoma. The evaluation of response to induction chemotherapy is a cornerstone in scheduling proper treatment management in patients affected by high-risk neuroblastoma. 123I-metaiodobenzylguanidine has been recognized as the radiopharmaceutical of choice in neuroblastoma assessment. To date, the clinical role of PET/CT in pediatric malignancy is not well established. 18F-DOPA-PET/CT has been recently used in neuroblastoma, and compared with 123I-MIBG-scan. Scant new data are available about the role of this tool in the evaluation of treatment response after induction chemotherapy. We investigate the role of 18F-DOPA-PET/CT in characterizing the response to induction chemotherapy in a child affected by high-risk- neuroblastoma, in whom the rare association of 123I-MIBG-negative primary tumor and MIBG-positive bone marrow metastases was observed.",
keywords = "Child, Neuroblastoma, Positron emission tomography/computed tomography",
author = "Arnoldo Piccardo and Egesta Lopci and Luca Foppiani and Giovanni Morana and Massimo Conte",
year = "2014",
doi = "10.1007/s00247-013-2807-x",
language = "English",
volume = "44",
pages = "355--361",
journal = "Pediatric Radiology",
issn = "0301-0449",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - 18F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma

AU - Piccardo, Arnoldo

AU - Lopci, Egesta

AU - Foppiani, Luca

AU - Morana, Giovanni

AU - Conte, Massimo

PY - 2014

Y1 - 2014

N2 - Functional imaging plays a crucial role in the assessment of neuroblastoma. The evaluation of response to induction chemotherapy is a cornerstone in scheduling proper treatment management in patients affected by high-risk neuroblastoma. 123I-metaiodobenzylguanidine has been recognized as the radiopharmaceutical of choice in neuroblastoma assessment. To date, the clinical role of PET/CT in pediatric malignancy is not well established. 18F-DOPA-PET/CT has been recently used in neuroblastoma, and compared with 123I-MIBG-scan. Scant new data are available about the role of this tool in the evaluation of treatment response after induction chemotherapy. We investigate the role of 18F-DOPA-PET/CT in characterizing the response to induction chemotherapy in a child affected by high-risk- neuroblastoma, in whom the rare association of 123I-MIBG-negative primary tumor and MIBG-positive bone marrow metastases was observed.

AB - Functional imaging plays a crucial role in the assessment of neuroblastoma. The evaluation of response to induction chemotherapy is a cornerstone in scheduling proper treatment management in patients affected by high-risk neuroblastoma. 123I-metaiodobenzylguanidine has been recognized as the radiopharmaceutical of choice in neuroblastoma assessment. To date, the clinical role of PET/CT in pediatric malignancy is not well established. 18F-DOPA-PET/CT has been recently used in neuroblastoma, and compared with 123I-MIBG-scan. Scant new data are available about the role of this tool in the evaluation of treatment response after induction chemotherapy. We investigate the role of 18F-DOPA-PET/CT in characterizing the response to induction chemotherapy in a child affected by high-risk- neuroblastoma, in whom the rare association of 123I-MIBG-negative primary tumor and MIBG-positive bone marrow metastases was observed.

KW - Child

KW - Neuroblastoma

KW - Positron emission tomography/computed tomography

UR - http://www.scopus.com/inward/record.url?scp=84899415680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899415680&partnerID=8YFLogxK

U2 - 10.1007/s00247-013-2807-x

DO - 10.1007/s00247-013-2807-x

M3 - Article

C2 - 24247818

AN - SCOPUS:84899415680

VL - 44

SP - 355

EP - 361

JO - Pediatric Radiology

JF - Pediatric Radiology

SN - 0301-0449

IS - 3

ER -